Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 24;14(7):e27194.
doi: 10.7759/cureus.27194. eCollection 2022 Jul.

Drug Therapy in Cognitive Disorders and Its Effects on Oral Health

Affiliations
Review

Drug Therapy in Cognitive Disorders and Its Effects on Oral Health

Syed Ershad Ahmed et al. Cureus. .

Abstract

Dementia and Alzheimer's disease are the two most characteristic cognitive disorders presenting numerous cognitive dysfunctions such as memory loss, functional impairment, speech impairment, and orientation problems. In India, there is an increased risk in the elderly population leading to the prevalence of Alzheimer's and dementia-related diseases. Therefore, it is not only general health care practitioners but also oral health care providers also play a major role in rehabilitating and treating this type of patient. So, it is necessary for oral health care providers to understand the pharmacologic agents used for the management of Alzheimer's and dementia-related diseases. This article gives an insight into the management of dementia and Alzheimer's disease and also an update on the drug therapies for AD and outlines their implications on oral health.

Keywords: alzheimer’s disease; cognitive dysfunctions; dementia; dental drugs; pharmacological agents.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Bird TD, Miller B. Harrison’s Neurology in Clinical Medicine. New York: McGraw-Hill; 2006. Alzheimer’s disease and other dementias.
    1. Clinical trials of new drugs for Alzheimer disease. Huang LK, Chao SP, Hu CJ. J Biomed Sci. 2020;27:18. - PMC - PubMed
    1. Alzheimer's disease: risk factors and potentially protective measures. Silva MV, Loures CM, Alves LC, de Souza LC, Borges KB, Carvalho MD. J Biomed Sci. 2019;26:33. - PMC - PubMed
    1. The dementia epidemic: impact, prevention, and challenges for India. Sathianathan R, Kantipudi SJ. Indian J Psychiatry. 2018;60:165–167. - PMC - PubMed
    1. Alzheimer’s & Related Disorders Society of India (2010). The Dementia India Report: prevalence,impact, costs and. [ Jan; 2010 ];https://www.mhinnovation.net/sites/default/files/downloads/innovation/re... 2010

LinkOut - more resources